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Human atherosclerotic plaques are characterized by local expansion of the vasa vasorum and development of 
intraplaque microvasculature. The extent of vascularization 
has been shown to correlate with progression stage, inflam-
matory content of the plaque, and plaque instability.1,2 Ever 
since Köster suggested that advanced atherosclerotic lesions 
are associated with an increased density in vasa vasorum,3 a 
growing number of studies have shown that both intraplaque 
microvasculature and vasa vasorum expansion enhance human 
atherosclerotic plaque progression.1,4,5 Intraplaque microves-
sels are thought to be derived mainly from the vasa vasorum by 
angiogenic sprouting, followed by ingrowth into the lesion.6–8 
The angiogenic response itself is considered to arise from the 
gradual development of lesional hypoxia attributable to (1) 
increased physical distance to the lumen, exceeding the dif-
fusion distance of oxygen, and (2) increased local metabolic 
activity of the plaque’s inflammatory content.1,9 Additionally, 
the endothelium of the newly formed microvessels is prone to 
continuous exposure to inflammatory mediators, which could 
lead to impaired functionality and increased permeability, 
caused by deteriorated interendothelial junctions and base-
ment membrane detachment.10 Dysfunctional microvessels 
would favor influx of circulating erythrocytes, leukocytes, and 
blood platelets into the plaque,6,7,11 thereby promoting plaque 
expansion, destabilization, and thrombogenicity.
Despite the clinical relevance of plaque neovascularization, 
experimental animal studies on functionality of plaque 
microvessels have been hampered by their low incidence, or even 
lack thereof, in mouse models of atherosclerosis. Proangiogenic 
interventions in murine models have shown to increase plaque 
development and disease burden,12–16 whereas antiangiogenic 
therapy decreases atherosclerosis development,17–20 implicating 
a potent role for angiogenesis in experimental atherosclerosis 
models. However, the interventions also influenced the 
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Objective—Neovascularization of human atherosclerotic plaques is implicated in plaque progression and destabilization, 
although its functional implications are yet unresolved. Here, we aimed to elucidate functional and morphological 
properties of plaque microvessels in mice in vivo.
Methods and Results—Atherosclerotic carotid arteries from aged (>40 weeks) apolipoprotein E–deficient mice were imaged 
in vivo using multiphoton laser scanning microscopy. Two distinct groups of vasa vasorum microvessels were observed 
at sites of atherosclerosis development (median diameters of 18.5 and 5.9 μm, respectively), whereas microvessels 
within the plaque could only rarely be found. In vivo imaging showed ongoing angiogenic activity and injection of 
fluorescein isothiocyanate-dextran confirmed active perfusion. Plaque vasa vasorum showed increased microvascular 
leakage, combined with a loss of endothelial glycocalyx. Mean blood flow velocity in plaque-associated vasa vasorum 
was reduced by ±50% compared with diameter-matched control capillaries, whereas mean blood flow was reduced 
8-fold. Leukocyte adhesion and extravasation were increased 6-fold in vasa vasorum versus control capillaries.
Conclusion—Using a novel in vivo functional imaging strategy, we showed that plaque-associated vasa vasorum were 
angiogenically active and, albeit poorly, perfused. Moreover, plaque-associated vasa vasorum showed increased 
permeability, reduced blood flow, and increased leukocyte adhesion and extravasation (ie, characteristics that could 
contribute to plaque progression and destabilization). (Arterioscler Thromb Vasc Biol. 2013;33:249-256.)
Key Words: angiogenesis ◼ atherosclerosis ◼ in vivo imaging ◼ microcirculation  
◼ multiphoton laser scanning microscopy
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inflammatory response, thereby affecting lesion development 
independent of plaque neovascularization. In general, animal 
studies have failed to show a direct causal relation between 
plaque vascularization, on the one hand, and plaque progression 
and destabilization, on the other.
Lack of adequate detection tools also hampered functional 
studies of plaque microvessels. Several methods like magnetic 
resonance imaging21,22 or micro- and nano-computed tomogra-
phy23 have been applied to investigate plaque vascularization in 
murine models of atherosclerosis. These methods lack the spatial 
and temporal resolution to detect functional and structural prop-
erties of individual microvessels, or to distinguish between the 
artery and microvessels. Also, these techniques lack the ability 
to detect multiple imaging probes simultaneously. Multiphoton 
laser scanning microscopy (MPLSM) can overcome these short-
comings and has previously been used for in situ imaging of 
healthy and atherosclerotic arteries at subcellular resolution,24,25 
as well as for quantifying angiogenic activity in models of 
tumor vascularization and myocardial infarction.26,27 In addition, 
MPLSM has been used to image large blood vessels in vivo, trig-
gered on heart rate and respiration to reduce motion artifacts.28,29 
More recently, MPLSM was used to quantify blood flow and 
hematocrit in blood vessels,30 substantiating MPLSM as a valu-
able tool for functional studies of the (micro)vasculature.
Here, we studied plaque microvessels to elucidate their 
structural and functional characteristics. Using MPLSM 
imaging in a novel in vivo imaging strategy, plaque microves-
sels could be visualized in aged apolipoprotein E–deficient 
(ApoE−/−) mice. More importantly, angiogenic activity could 
be visualized and functional characteristics, including blood 
flow, adhesion and extravasation of leukocytes, and microvas-
cular permeability, could be quantified and were found to dif-
fer significantly from control microvascular beds.
Methods
Animals
For ex vivo and in vivo experiments, aged ApoE−/− mice (40–50 weeks 
of age; n=51) with advanced atherosclerotic plaques were used. Young 
ApoE−/− mice (12–16 weeks of age; n=8), without or with only initial 
atherosclerotic plaques, and age-matched wild-type C57Bl/6 mice 
(n=20) served as controls. Mice were supplied by the institutional 
animal facility and were housed in conventional cages and received 
a normal chow diet. Experiments were approved by the local animal 
ethics committee and performed according to institutional guidelines.
Imaging
MPLSM imaging was performed on a Leica SP5 imaging platform 
(Leica Microsystems) that integrates multiphoton microscopy with 
fast resonant scanning, and uses a Compact Ultrafast Ti:Sapphire Laser 
(Chameleon, Coherent). Anti-CD31 antibody (BD Pharmingen) was 
used to detect vascular endothelium, and cyclic Asn–Gly–Arg was used to 
target CD13, a marker of angiogenic vascular endothelium. Biotinylated 
anti–Ephrin-B2 and anti–EphB4 (R&D Systems) antibodies were 
used to assess arterial or venous lineage of microvessels, respectively. 
Biotinylated antibodies were conjugated with streptavidin-quantum 
dot 525 (green) or streptavidin-quantum dot 585 (red) as indicated. To 
examine perfusion of microvessels and microvascular permeability, 70- 
and 150-kDa fluorescein isothiocyanate-labeled dextrans (Sigma) were 
used. For studying blood flow and leukocyte trafficking, leukocytes were 
labeled using Rhodamin 6G or Cell Tracker Red (CMTPX, Invitrogen).
Statistics
Data are presented as mean±SEM, unless stated otherwise. Statistics 
were performed using Graphpad Prism 5.0 or PASW Statistics 18. 
The nonparametric Mann-Whitney U test was applied to adhesion, 
extravasation, and blood flow velocity data. Microvascular perme-
ability data were analyzed using curve fitting regression analysis. 
Fisher exact test was used for examining differences between groups 
for presence of plaque-associated microvasculature. Results were 
considered statistically different when P<0.05. Expanded methods 
are available in the online-only Data Supplement.
Results
Vasa Vasorum Were Visualized and 
Morphologically Characterized In Vivo
The vasa vasorum were studied in detail using in vivo and in 
situ MPLSM after labeling with anti-CD31, allowing charac-
terization of microvessel morphology throughout the adven-
titia. Characteristics like microvessel diameter were similar 
in the adventitia of the carotid artery and abdominal aorta 
(Table 1). Based on the size and orientation, 2 types of plaque-
specific microvessels could be discriminated. The larger vasa 
vasorum microvessels (median diameter, 18.5 μm) generally 
ran in parallel to the artery, whereas smaller microvessels 
(median diameter, 5.9 μm) mostly covered the artery radially. 
The adventitia surrounding the atherosclerotic plaque showed 
several microvessels (Figure 1A and 1B, Movies I and II in the 
online-only Data Supplement), which was confirmed by immu-
nohistochemistry for CD31 and von Willebrand factor (Figure 
I in the online-only Data Supplement). Microvessels in peri-
adventitial fat were excluded from analysis based on collagen 
imaging of the adventitia using second harmonic generation 
and imaging of autofluorescence of the peri-adventitial fat. 
Microvessels were mostly situated within 40 to 80 μm from 
the outer elastic lamina, but occasionally—at sites of large 
advanced plaques—microvessels would be situated within 15 
to 20 μm from the outer elastic lamina. Vasa vasorum were 
Table 1. Quantification of Microvessel Diameter From Plaque-Associated Microvessels in the Carotid Artery and Abdominal Aorta.
Location Median, μm Range, μm Total No. of Microvessels (Total No. Mice)
Carotid artery Intraplaque 6.65 4.42–9.02 6 (20)
Adventitial (large; >10 µm) 18.5 10.5–21.2 71 (39)
Adventitial (small; <10 µm) 5.9 5.56–6.23 56 (39)
Abdominal aorta Intraplaque ND ND ND
Adventitial (large; >10 µm) 22.7 16.6–43.8 8 (8)
Adventitial (small; <10 µm) 6.0 2.1–16.5 5 (8)
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exclusively located at atherosclerotic foci around the carotid 
bifurcation and were neither observed further upstream at the 
nondiseased common carotid artery nor in younger ApoE−/− 
mice or age-matched C57Bl/6 controls (Table 2). Individual 
endothelial cells (Figure 1C, arrowheads) of the vasa vasorum 
and their nuclei (Figure 1C, arrows) could be delineated.
In vivo measurements displayed a predominantly arterial 
phenotype of the vasa vasorum (Figure 1D), as observed by 
Ephrin-B2 and Eph-B4 staining. Moreover, on local or bilat-
eral ligation of the jugular vein for up to 30 minutes, functional 
parameters (eg, microvessel diameter) remained unaltered 
(Figure II in the online-only Data Supplement), arguing a mar-
ginal role of the venous system in controlling the vasa vasorum.
Plaque-Associated Vasa Vasorum Showed 
Angiogenic Activity In Vivo
The particular localization of the microvasculature at sites of 
plaque formation and absence of microvasculature in young 
atherosclerotic mice suggests angiogenesis underlies the 
development of these microvessels. Therefore, a cyclic Asn–
Gly–Arg probe targeting the angiogenic marker CD13 and 
specific for angiogenic endothelium on in vivo injection26 was 
used to investigate whether ongoing angiogenesis was present. 
The vasa vasorum showed CD31+/CD13– microvessels 
accompanied by occasional CD31low/CD13+ sprouts (Figure 
1E). At the site of sprouting, part of the endothelium expressed 
both CD31 and CD13 (Figure 1E, inset).
Plaque-Associated Vasa Vasorum Were 
Actively Perfused and Hyperpermeable
Because the normal physiology and perfusion of vasa 
vasorum microvessels were unknown, this was assessed 
by injection of 70-kDa and 150-kDa fluorescein isothio-
cyanate-dextrans, which indicated active perfusion (Figure 
1F, green) of the vasa vasorum (red: CD31) in vivo. Also, 
sprouting of new microvessels was observed (Figure 1F, 
arrowhead), with new sprouts displaying low CD31 expres-
sion. Additionally, a rise in fluorescence intensity (ie, dex-
tran concentration) in the adventitia was observed (Figure 
1F, asterisk).
Concurrently, dextran injection allowed measurement of 
microvascular permeability by calculating the time-dependent 
rise in extraluminal fluorescence intensity compared with 
intraluminal fluorescence intensity. Although intraluminal 
dextran levels remained constant for >60 minutes, the extralu-
minal content of 70-kDa dextran increased with time to an 
extraluminal/intraluminal ratio of ≈0.46 after 35 minutes in 
Figure 1. Plaque-associated vasa vasorum of atherosclerotic plaques at the carotid artery bifurcation in aged apolipoprotein E–deficient 
(ApoE−/−) mice could be detected using multiphoton laser scanning microscopy (MPLSM). Three-dimensional rendering of the carotid 
artery directly proximal from the bifurcation and viewed from the luminal side depicts vasa vasorum (green, arrows) embedded in adven-
titial collagen (blue; A, Movie I in the online-only Data Supplement). Plaque autofluorescence in green (P) is also visible. When focusing 
merely on the adventitia, the vasa vasorum is clearly detectable (B, green; Movie II in the online-only Data Supplement). C, Single CD31+ 
(red, arrowheads) endothelial cells including nuclei (green, arrow) were detected. When assessing arterial/venous lineage of the vasa 
vasorum, microvessels were found to be predominantly arterial in origin as shown by Ephrin-B2 staining (D, red), whereas the venous 
marker Eph-B4 (green) was not detectable. Using a cyclic Asn–Gly–Arg (cNGR) probe (red, inset figure E) to detect angiogenic endothe-
lium, angiogenic sprouting from a preexisting vasa vasorum vessel (green) was detected. CD31+ vasa vasorum vessels (red, arrows), 
as well as new sprouts (CD31low, arrowhead), are actively perfused as determined by a fluorescein isothiocyanate (FITC)-labeled (green) 
70-kDa dextran (F). Leakage of dextran into tissue surrounding the vasa vasorum could be detected (F, *). Dotted lines indicate the outline 
of the carotid artery, which is situated below the vasa vasorum. Bars indicate 100 μm (A and B) or 25 μm (C–F).
Table 2. Prevalence of Adventitial Vasa Vasorum in the Carotid 
Artery in the Various Experimental Groups
Adventitial Microvessels
Genotype No. of Mice No Yes % Present
C57Bl/6 20 20  0 0*
ApoE−/− (<16 wk)  8  7  1 12.5*
ApoE−/− (>40 wk) 51  6 45 88.2*
ApoE−/− indicates apolipoprotein E–deficient.
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plaque-associated vasa vasorum (Figure 2A-1 and 2B-1). 
Because vasa vasorum, in accordance with literature,19,31 was 
not observed in nondiseased arteries, we used the similar 
sized microvasculature of the nearby sternohyoid muscle as 
a control. In the sternohyoid muscle, only a limited increase 
in extravascular dextran concentration was observed (Figure 
2A-2 and 2B-2). On quantification, extravascular dextran con-
centration (Figure 2C, black line, P<0.05) was significantly 
increased only in vasa vasorum, but not in control microvessels 
(Figure 2C, dotted line), indicative of enhanced microvascular 
permeability in the vasa vasorum. Additionally, extravasation 
of 70-kDa dextran occurred earlier in vasa vasorum compared 
with control microvessels (Figure 2C). Because of myocyte 
autofluorescence, baseline extra/intraluminal fluorescence 
ratios varied slightly; however, all experiments showed an 
identical pattern of significantly increased microvascular per-
meability of the vasa vasorum. Of note, microvascular extra-
vasation of 150-kDa dextran did not significantly increase 
over time, neither in the vasa vasorum or in control microves-
sels (not shown).
A size-dependent increase in permeability could be caused 
by several mechanisms. It is known that reduction or absence 
of endothelial glycocalyx in microvessels can, independently 
from the interendothelial junctions, lead to increased perme-
ability and leukocyte adhesion.32 In addition, disruption of the 
endothelial barrier may cause hyperpermeability. To deter-
mine what caused the increased permeability, we examined 
glycocalyx integrity by wheat germ agglutinin staining and 
analyzed the integrity of the interendothelial junctions by 
electron microscopy. Staining for wheat germ agglutinin in 
vivo showed an irregular staining pattern in the vasa vasorum 
(Figure 2D), contrary to an evenly distributed expression of 
glycocalyx throughout control microvessels in the sterno-
hyoid muscle (Figure 2E; Figure III in the online-only Data 
Supplement). The interendothelial junctions were intact as 
shown by electron microscopy (Figure 2F and 2G; arrows), 
and occasionally, pericytes (P) were found covering the 
microvascular endothelium. The endothelial cells did, how-
ever, show initial signs of membrane blebbing, indicative of 
early endothelial dysfunction.
Plaque-Associated Vasa Vasorum Showed 
Decreased Blood Flow, Yet an Increased 
Adhesion and Extravasation of Leukocytes
Leukocytes were observed within the vasa vasorum after in 
vitro (Figure 3A) and in vivo (Figure 3B, Figure II in the online-
only Data Supplement) labeling. Using labeled leukocytes and 
platelets, blood flow velocity and blood flow were assessed 
in the carotid artery, vasa vasorum, and control microvessels. 
Both blood flow velocity (2.1-fold decrease, P<0.001; Figure 
3C, Table I in the online-only Data Supplement) and blood 
flow (7.6–9.8-fold decrease, P<0.001; Figure 3D) were sig-
nificantly reduced in vasa vasorum compared with control 
microvessels. Changes in blood flow and flow velocity were 
independent of microvessel diameter. Blood flow direction 
was identical to the main artery.
Figure 2. Microvascular permeability was calculated from the ratio of the extraluminal/intraluminal fluorescence intensity of 70-kDa fluo-
rescein isothiocyanate (FITC)-dextran. Extraluminal fluorescence intensity increased over time, as depicted for t=3 and t=35 minutes after 
injection (A-1 and B-1, respectively) for vasa vasorum, whereas only a limited increase in fluorescence intensity was observed for the 
control sternohyoid muscle at the same time points (A-2 and B-2, respectively). The ratio extraluminal/intraluminal fluorescence intensity 
was calculated for different time points, as shown in a representative plot (C). Over time, the extraluminal presence of 70-kDa FITC-
dextran increased significantly in the vasa vasorum (black line), but not in control microvessels (dotted line). No significant microvascular 
leakage was observed for 150-kDa dextrans in either vessel types (not shown). In plaque-associated vasa vasorum (D), the glycocalyx 
(green: wheat germ agglutinin [WGA]) was present in only a small part of the microvessel (arrow; red: CD31). In contrast, the glycocalyx 
was consistently present in control microvessels in the sternohyoid muscle (E). Interendothelial junctions in plaque-associated vasa vaso-
rum were, however, intact (F, higher magnification in G; arrows), although the endothelial cells did show signs of membrane blebbing (*). 
Pericytes (P) surrounding the endothelial cells were also found. Dotted line indicates the outline of the carotid artery, which is situated 
below the vasa vasorum; bars indicate 25 μm (A–E).D
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Additionally, adhesion and transmigration of ex vivo and 
in vivo labeled leukocytes were significantly increased com-
pared with control microvessels (Figure 4). Increased adhe-
sion (Figure 4A, 1.3×10−2±0.3×10−2 versus 0.2×10−2±0.1×10−2 
cells/mm2 per minute, P<0.05) and extravasation (Figure 
4B, 1.8×10−2±0.4×10−2 versus 0.3×10−2±0.2×10−2 cells/mm2 
per minute, P<0.05) of leukocytes were observed in plaque-
associated vasa vasorum and control microvessels, respec-
tively. Leukocyte adhesion and extravasation were examined 
in more detail ex vivo, using 3-dimensional image analysis. 
Cell morphology suggested transmigration of different leuko-
cyte subtypes, including pseudopodia-rich cells resembling 
a dendritic morphology, from the vasa vasorum toward the 
plaque (Figure 4C and 4D, Movie III in the online-only Data 
Supplement).
Ex Vivo MPLSM Confirmed Presence of Vasa 
Vasorum and Intraplaque Microvascular Structures
Plaque-associated vasa vasorum were also imaged ex vivo, 
allowing imaging at higher resolution and signal-to-noise 
Figure 3. Cellular perfusion (A; green, arrow) of 
vasa vasorum (A; red) in aged apolipoprotein E–
deficient (ApoE−/−) mice. A, Vascular endothelium 
(red) and elastin autofluorescence (green) of the 
carotid artery are also visible. Leukocytes (B; red) 
adhered to (yellow arrow) or extravasated from 
(white arrow) the vasa vasorum (B; green). Dotted 
lines indicate the outline of the carotid artery, situ-
ated below the vasa vasorum; bars indicate 25 μm. 
Leukocyte velocity in vasa vasorum (black bars, 
C) is significantly reduced compared with control 
microvessels (white bars, C). Blood flow in vasa 
vasorum is also significantly lower than in control 
microvessels (D). Dotted line indicates the outline of 
the carotid artery; bars indicate 25 µm.
Figure 4. In aged apolipoprotein E–
deficient (ApoE−/−) mice, adhesion and 
extravasation were significantly increased 
in vasa vasorum compared with control 
microvessels of similar diameters (A and 
B). This is accompanied by decreased 
blood flow (see Figure 3C and 3D). Three-
dimensional reconstruction (C and D) of 
in situ z-scan showed adhering (yellow 
arrow) and transmigrated cells (white 
arrows), as well as cells in the progress 
of transmigration through the microvessel 
wall (yellow arrowheads). Multiphoton 
laser scanning microscopy (MPLSM) 
allowed differentiation of morphologically 
distinct cell types (eg, pseudopodia-rich 
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ratio without motion artifacts. For ex vivo imaging, the carotid 
artery or abdominal aorta was excised, mounted in a perfu-
sion chamber and imaged under a transmural pressure of 80 
mm Hg to mimic physiological conditions.24 Ex vivo imag-
ing was performed up to 30 μm from the outer elastic lamina. 
Vasa vasorum were detected both in the carotid artery and 
abdominal aorta (Table 1).
Ex vivo imaging clearly visualized intraplaque microvas-
cular structures (Figure IVA and IVB in the online-only Data 
Supplement), yet intraplaque microvessels were only found in 
6 of 20 plaques (Table II in the online-only Data Supplement). 
Surprisingly, none of these microvessels derived from the 
vasa vasorum. Rather, data suggested that these microves-
sels originated from endothelial sprouting from the luminal 
endothelial layer (3 of 6 plaques; Figure IVC in the online-
only Data Supplement). No functional characteristics could 
be determined for intraplaque vessels, arguing a limited role 
for intraplaque microvessels in this model. Also, occurrence of 
intraplaque hemorrhage (IPH) was determined in aged ApoE−/−, 
and was found in 4 of 20 (20%) mice examined. Although all 
mice that showed IPH also showed vasa vasorum, only a minor 
fraction of vasa vasorum–containing plaques showed features 
of IPH. Occurrence of IPH could not be linked to occurrence 
of luminal microvascular structures.
Discussion
The presence and role of plaque-associated microvessels in 
murine plaques have been extensively debated in literature. 
Previous attempts to detect these microvessels yielded varying 
results, in part depending on the animal model and visualiza-
tion techniques used. Here, we used in vivo MPLSM to show 
that plaque-associated vasa vasorum (1) are present in ApoE−/− 
mice; (2) show angiogenic activity; (3) are actively perfused 
and hyperpermeable; (4) have significantly reduced blood 
flow and blood flow velocity compared with control microves-
sels with similar diameter, and (5) show enhanced leukocyte 
adhesion and transmigration at the site of the athero sclerotic 
plaque. Taken together, we show that plaque-associated 
microvessels exhibit functional features that could facilitate 
plaque development and progression.
The increased adhesion of leukocytes may, in part, be a con-
sequence of the reduction in blood flow velocity, because this 
would cause a reduction in local shear stress at the microvas-
cular wall. Consequently, low shear stress is deemed to cause 
endothelial cell dysfunction and upregulation of adhesion 
molecules like vascular cell adhesion molecule-1 and intercel-
lular adhesion molecule-1.33–35 The increased leukocyte adhe-
sion was accompanied by augmented transmigration to the 
adventitial tissue, facilitating a second site of ingress of leu-
kocytes, besides migration through the luminal endothelium. 
These cells may contribute to further plaque development, 
either by functioning in the adventitia itself, or by infiltration 
into the plaque after migrating through the media. As such, the 
vasa vasorum could contribute to exacerbation of atheroscle-
rosis, by infiltration of new inflammatory cells.36
Additionally, vasa vasorum hyperpermeability may be 
another important contributor to plaque progression, as it 
favors extravasation of lipids and plasma proteins at sites 
of plaque development.37 Increased permeability may be 
attributed to disruption of the endothelial barrier function.10 
Our finding of augmented microvascular extravasation in the 
vasa vasorum, at least for molecules with a molecular weight 
of up to 70 kDa, suggests that abundant plasma proteins, such 
as albumin, can leak into the adventitia. Indeed, extravascular 
albumin has been detected in both human and mouse athero-
sclerotic lesions.38,39 Here, we extend these findings, demon-
strating an apparent size limit for endothelial leakage in vasa 
vasorum of 70 to 150 kDa in vivo in aged ApoE−/− mice. The 
origin of the microvascular hyperpermeability remains to be 
further elucidated. Electron microscopy did not show any aber-
rations in endothelial cell junctions, concordant with a recent 
study from Eriksson.31 However, the endothelial glycocalyx 
of plaque-associated vasa vasorum was disrupted, indicating 
a possible cause for the increase in vascular permeability, and 
more specifically, permeability for smaller molecules. Both 
the increased leukocyte extravasation and hyperpermeability 
will affect plaque development and progression, especially 
when plaques become more advanced and vasa vasorum has 
expanded by increasing adventitial inflammation. As such, 
these processes could enhance plaque progression indepen-
dent of microvascular disruption and hemorrhage.
Vasa vasorum were abundantly present at sites of athero-
sclerotic plaques, sites at which we also observed an increase 
in vessel wall thickness (not shown). Thickening of the vessel 
wall may infer an increase in vascularization, because oxygen-
ation of the entire tissue is hindered by vessel wall thickening, 
potentially increasing local hypoxia. Remarkably, although 
the entire carotid artery was examined, we did not observe 
any vascularization of nonatherosclerotic segments, neither in 
control animals nor in the young or aged ApoE−/− mice. This 
is consistent with reports by, for example, Gräbner et al40 or 
Eriksson.31 Given the fact that vasa vasorum were absent in 
nonatherosclerotic segments, we chose the sternohyoid micro-
vasculature as a substitute model for general microvascular 
blood flow. Taken together, development of vasa vasorum in 
ApoE−/− mice appears to be an adaptive response to pathologi-
cal, atherosclerosis-induced vessel wall changes.
Many studies have suggested a role for angiogenesis in 
atherosclerosis. Proatherogenic effects of increased angio-
genesis and antiatherogenic effects on decreased angiogenesis 
have been described in models of pharmacological stimula-
tion or inhibition of angiogenesis,18,19,41 as well as in certain 
animal models (eg, the collagen-XVIII/ApoE double knock-
out mouse).15 Here, presence of CD13+/CD31low sprouts in the 
adventitia substantiates the presence of ongoing angiogenesis. 
The reduced expression of CD31 is in accordance with studies 
that have shown that both embryonic stem cells and mature 
endothelial cells show reduced expression of CD31 during 
endothelial differentiation, migration, and proliferation.42,43 It 
is, however, surprising that the plaque-associated vasa vaso-
rum showed an almost exclusively arterial phenotype, which 
is in contrast to the model suggested by Eriksson.31 Possibly, 
this is attributable to differences in experimental setup, as the 
current study was performed on mice without a diet and at a 
younger age than the mice used by Eriksson, resulting in a 
less developed vasa vasorum. On the other hand, it should be 
noted that Ephrin-B2 is known to be expressed on angiogenic 
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Ephrin-B2 staining. However, because there was no response 
to venous ligation, it is conceivable that the vasa vasorum in 
fact may drain on the carotid artery, acting comparable with an 
arterial shunt. This would explain the low flow, which could be 
a consequence of a small pressure gradient over the vasa vaso-
rum, although the latter may also be influenced by pulsation 
caused by systolic and diastolic phases of the cardiac cycle.
Whereas plaque-associated microvessels were primar-
ily located in the adventitia surrounding the atherosclerotic 
lesion, vessel-like structures were sporadically detected 
within the plaque itself (Table II in the online-only Data 
Supplement). Surprisingly, these structures did not origi-
nate from the vasa vasorum, because microvessels did not 
traverse the media. These findings oppose observations in 
human plaques.8 Of note, incidental sprouting from the lumi-
nal endothelium was observed, yet these intraplaque vascular 
structures did not seem to be functionally perfused in vivo. 
Lucerna et al13 showed that overexpression of vascular endo-
thelial growth factor in mice led to more luminal invagin-
ations, accompanied by an increased leukocyte influx into the 
plaque. Therefore, intraplaque microvascular structures, even 
when originating from the lumen, may contribute to the pro-
gression of atherosclerotic plaques in mice. Additionally, inti-
mal microvessels are suggested to be causal for IPH, although 
no causal link between IPH and plaque vascularization could 
be discerned. The observed occurrence of IPH was within the 
range described in, for example, the studies from Rosenfeld,44 
Calara,45 and Johnson,46 which however show a large variation 
in the occurrence of IPH (3.6%–75%). Generally, proof of a 
causal relationship between vascularization and IPH is lacking 
in murine models, which is substantiated by our current study. 
The data, however, are suggestive of a contribution of vasa 
vasorum to IPH, or plaque instability in general, although the 
presence of vasa vasorum does not infer occurrence of IPH.
Although this murine model does not completely mimic 
human atherosclerosis, because it only shows a limited, yet 
consistent occurrence of (intraplaque) vascularization, it pro-
vides new insights into the potential role of vasa vasorum 
in human atherosclerosis. Importantly, a number of features 
found in our study are consistent with previous studies in 
human atherosclerosis. For example, human plaque microves-
sels have been associated with ingress of leukocytes and 
erythrocytes and with leakage of albumin.2 In this study, we 
established increased leukocyte adhesion and extravasation 
from adventitial microvessels, as well as an increased perme-
ability of microvessels for 70-kDa dextrans, resembling albu-
min leakage in human atherosclerosis. Interestingly, and in 
contrast to our model, human plaque microvessels generally 
seem to have a more instable microvascular phenotype and 
show disrupted interendothelial junctions,10 especially in intra-
plaque microvessels. Hence, it would be interesting to investi-
gate functional features of plaque neovascularization in other 
murine models, which have already described intraplaque 
microvessels or more extensive vasa vasorum expansion.15,47
In summary, using a novel in vivo imaging strategy, we 
were able to study plaque-associated microvessels in mice and 
quantify its functional characteristics. The plaque-associated 
vasa vasorum demonstrated a significantly reduced blood 
flow, blood flow velocity, as well as an increase in leukocyte 
adhesion, leukocyte transmigration, and endothelial permea-
bility compared with control microvasculature. In conjunction 
with the ongoing angiogenic activity, these features would 
support progression of atherosclerotic lesions. Further studies 
will help unravel by which means microvascular function in 
the vasa vasorum may be normalized.
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